Article
The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells
27 Dec 2019
Abstract excerpt
The clinical success of chimeric antigen receptor (CAR) T cell immunotherapy in the treatment of haematological cancers has encouraged the extensive development of CAR design to improve their function and increase their applicability. Advancements in protein engineering have seen modifications to both the ecto- and endo-domains of the CAR, with recent designs targeting multiple antigens and including inducible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
